CDKN2A and myocardial infarction: It has been shown that in a transgenic mouse model that allows for specific inactivation of the p16ink4 gene (cdkn2a) in cardiomyocytes, cardiac dysfunction caused by myocardial infarction is significantly improved, and scar size is reduced [53].